Rexcin Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 2.80 M
as on 10-07-2024
- Paid Up Capital ₹ 0.20 M
as on 10-07-2024
- Company Age 21 Year, 4 Days
- Last Filing with ROC 31 Mar 2023
- Revenue -37.90%
(FY 2019)
- Profit 107.51%
(FY 2019)
- Ebitda 95.30%
(FY 2019)
- Net Worth 0.38%
(FY 2019)
- Total Assets -3.06%
(FY 2019)
About Rexcin Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.80 M and a paid-up capital of Rs 0.20 M, as per Ministry of Corporate Affairs (MCA) records.
Pradeep Saxena and Satinder Singh serve as directors at the Company.
- CIN/LLPIN
U24239DL2003PTC123544
- Company No.
123544
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 Dec 2003
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
West Delhi, Delhi, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Rexcin Pharmaceuticals Private Limited offer?
Rexcin Pharmaceuticals Private Limited offers a wide range of products and services, including Common Disease Medicines, Antihistamines, Pharma Ingredients & Raw Materials, Anti Infective API, Brain & Nervous System Drugs, Antidepressant & Anti Anxiety Medicines, Psoriasis Ointment.
Who are the key members and board of directors at Rexcin Pharmaceuticals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pradeep Saxena  | Director | 17-Mar-2011 | Current |
| Satinder Singh | Director | 15-Jul-2015 | Current |
Financial Performance and Corporate Structure Insights of Rexcin Pharmaceuticals.
Rexcin Pharmaceuticals Private Limited, for the financial year ended 2019, experienced significant reduction in revenue, with a 37.9% decrease. The company also saw a substantial improvement in profitability, with a 107.51% increase in profit. The company's net worth moved up by a moderate rise of 0.38%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Rexcin Pharmaceuticals?
In 2019, Rexcin Pharmaceuticals had a promoter holding of 100.00%. The company had 1 Subsidiary and 2 Associate Companies. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Rexcin Healthcare Private LimitedActive 21 years 4 daysPradeep Saxena and Satinder Singh are mutual person
- Rexcin Drugs Private LimitedActive 21 years 4 days
Pradeep Saxena and Satinder Singh are mutual person
- Best Laboratories Private LimitedActive 21 years 2 days
Pradeep Saxena and Satinder Singh are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Rexcin Pharmaceuticals?
Rexcin Pharmaceuticals has a workforce of 1 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Rexcin Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rexcin Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
